Attentive Science at the ACT 2026 Annual Meeting

Attentive Science is heading to San Antonio for the 47th Annual Meeting of the American College of Toxicology (ACT 2026), November 15–18 at the JW Marriott San Antonio Hill Country. This meeting unites toxicologists, regulatory experts and nonclinical scientists who share one goal: bringing safer therapies to patients faster.

The Attentive Team will be on the exhibit floor, eager to meet biotech and pharmaceutical teams seeking a dependable preclinical CRO partner. From protocol development through GLP-compliant study conduct and reporting, we help sponsors reduce development risk, keep programs on schedule and move confidently toward IND submission.

Find Us at Booth 211

Visit Booth 211 for a conversation with our experts about:

Toxicology program design: GLP and non-GLP in vivo studies tailored to your test article and milestones
Clear, decision-ready data: expert toxicology and pathology interpretation that supports your next go/no-go call
Support built for emerging biotech: practical study strategies for startup and mid-sized companies managing tight budgets and timelines
Partnership that de-risks development: close collaboration with our study directors at every stage of your program

Whether you're preparing a first-in-human candidate or growing a broader pipeline, we look forward to exploring how Attentive Science can help you reach your next milestone.

Meet Our Team in San Antonio

Will you be at ACT 2026? Book a meeting with our team in advance, or drop by Booth 211 any time during the exhibit hours.

Together, let's design nonclinical programs that are faster, safer and built for regulatory success, from early discovery to IND filing.